Ayşe Erbay

2.7k total citations
87 papers, 1.6k citations indexed

About

Ayşe Erbay is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ayşe Erbay has authored 87 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 19 papers in Infectious Diseases and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ayşe Erbay's work include Viral Infections and Vectors (9 papers), Brucella: diagnosis, epidemiology, treatment (9 papers) and Antibiotic Resistance in Bacteria (8 papers). Ayşe Erbay is often cited by papers focused on Viral Infections and Vectors (9 papers), Brucella: diagnosis, epidemiology, treatment (9 papers) and Antibiotic Resistance in Bacteria (8 papers). Ayşe Erbay collaborates with scholars based in Türkiye, United States and Serbia. Ayşe Erbay's co-authors include Hürrem Bodur, Esragül Akıncı, Neriman Balaban, Aylin Çolpan, Mustafa Aydın Çevik, Pınar Öngürü, Ayhan Kubar, Önder Ergönül, Aliye Baştuğ and Çiğdem Kader and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and International Journal of Antimicrobial Agents.

In The Last Decade

Ayşe Erbay

76 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ayşe Erbay Türkiye 23 570 479 346 297 243 87 1.6k
Esragül Akıncı Türkiye 24 839 1.5× 398 0.8× 472 1.4× 269 0.9× 168 0.7× 78 1.7k
Sang Taek Heo South Korea 25 951 1.7× 521 1.1× 312 0.9× 496 1.7× 126 0.5× 129 2.0k
Hürrem Bodur Türkiye 33 1.7k 3.0× 533 1.1× 935 2.7× 275 0.9× 223 0.9× 125 2.8k
Yong Pil Chong South Korea 28 1.5k 2.6× 1.0k 2.1× 432 1.2× 459 1.5× 187 0.8× 200 2.8k
Necla Tülek Türkiye 22 330 0.6× 466 1.0× 178 0.5× 125 0.4× 62 0.3× 90 1.2k
Denis W. Spelman Australia 25 480 0.8× 534 1.1× 205 0.6× 811 2.7× 193 0.8× 80 2.2k
İftihar Köksal Türkiye 25 1.3k 2.2× 820 1.7× 603 1.7× 377 1.3× 216 0.9× 139 2.5k
E. Dale Everett United States 23 1.1k 1.9× 655 1.4× 699 2.0× 144 0.5× 128 0.5× 48 2.5k
Imad Kassis Israel 23 648 1.1× 967 2.0× 481 1.4× 287 1.0× 180 0.7× 110 2.3k
İrfan Şencan Türkiye 22 589 1.0× 385 0.8× 368 1.1× 63 0.2× 61 0.3× 119 1.5k

Countries citing papers authored by Ayşe Erbay

Since Specialization
Citations

This map shows the geographic impact of Ayşe Erbay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayşe Erbay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayşe Erbay more than expected).

Fields of papers citing papers by Ayşe Erbay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayşe Erbay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayşe Erbay. The network helps show where Ayşe Erbay may publish in the future.

Co-authorship network of co-authors of Ayşe Erbay

This figure shows the co-authorship network connecting the top 25 collaborators of Ayşe Erbay. A scholar is included among the top collaborators of Ayşe Erbay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayşe Erbay. Ayşe Erbay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kader, Çiğdem, et al.. (2017). BRUSELLOZ OLGULARININ DEĞERLENDİRİLMESİ Evaluation of Brucellosis Cases. DergiPark (Istanbul University).
2.
Kader, Çiğdem, et al.. (2017). Antibodies against vaccine preventable diseases in pregnant women measles, mumps, rubella, varicella and tetanus in Yozgat, Turkey. Konuralp Tıp Dergisi. 29–34. 2 indexed citations
3.
Kader, Çiğdem, et al.. (2014). Early Use of Ribavirin Is Beneficial in Crimean-Congo Hemorrhagic Fever. Vector-Borne and Zoonotic Diseases. 14(4). 300–302. 34 indexed citations
4.
Erbay, Ayşe, et al.. (2014). An Outbreak of Streptococcus pyogenes Surgical Site Infections in a Cardiovascular Surgery Department. Surgical Infections. 16(2). 151–154. 2 indexed citations
5.
Kader, Çiğdem, et al.. (2013). Evaluation of mean platelet volume (MPV) levels in brucellosis patients. Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi. 35(4). 488–494. 2 indexed citations
6.
Ergin, Hacer, et al.. (2013). A Newborn with Congenital Mixed Phenotype Acute Leukemia After In Vitro Fertilization. Pediatrics & Neonatology. 56(4). 271–274. 4 indexed citations
7.
Kader, Çiğdem, et al.. (2012). Ülseroglandüler tularemi: Olgu sunumu. Klimik Dergisi/Klimik Journal. 25(1). 31–34. 1 indexed citations
8.
Çelikbaş, Aysel Kocagül, et al.. (2012). The Evaluation of Virological and Immunological Response to Antiretroviral Therapy in HIV/AIDS Cases. ANKEM Dergisi. 25(4). 215–219.
9.
Bodur, Hürrem, et al.. (2010). Effect of oral ribavirin treatment on the viral load and disease progression in Crimean-Congo hemorrhagic fever. International Journal of Infectious Diseases. 15(1). e44–e47. 40 indexed citations
10.
Erbay, Ayşe, et al.. (2009). Evaluation of Epidemiological, Clinical and Laboratory Features of HIV/AIDS Cases. SHILAP Revista de lepidopterología. 1 indexed citations
11.
Erbay, Ayşe. (2008). Effect of Oral Ribavirin Treatment to the Viral Load and Progress of the Disease in Crimean Congo Hemorrhagic Fever. 46th Annual Meeting. 2 indexed citations
12.
Akıncı, Esragül, İpek Mumcuoğlu, Pınar Öngürü, et al.. (2008). In Vitro Activity of Tigecycline Against Acinetobacter baumannii Strains Isolated From Nosocomial Infections. TURKISH JOURNAL OF MEDICAL SCIENCES. 38(6). 583–586. 5 indexed citations
13.
Erbay, Ayşe, et al.. (2007). Evaluation of the Attitudes and Behaviors of Health Care Workers Toward Influenza Vaccine in Ankara Numune Education and Research Hospital. SHILAP Revista de lepidopterología.
14.
Aktaş, Safiye, Aydanur Kargı, Nur Olgun, et al.. (2007). Prognostic Significance of Cell Proliferation and Apoptosis-Regulating Proteins in Epstein-Barr Virus Positive and Negative Pediatric Hodgkin Lymphoma. Lymphatic Research and Biology. 5(3). 175–182. 14 indexed citations
15.
Çolpan, Aylin, Pınar Öngürü, Ayşe Erbay, et al.. (2007). Fever of Unknown Origin: Analysis of 71 Consecutive Cases. The American Journal of the Medical Sciences. 334(2). 92–96. 33 indexed citations
16.
Öztoprak, Nefise, et al.. (2005). Herpes Simplex Encephalitis: A Case Report. SHILAP Revista de lepidopterología. 1 indexed citations
17.
Akıncı, Esragül, et al.. (2005). Risk factors for ICU-acquired imipenem-resistant Gram-negative bacterial infections. Journal of Hospital Infection. 59(4). 317–323. 31 indexed citations
18.
Bodur, Hürrem, et al.. (2005). A complication of brucellosis: Epididymoorchitis. International Journal of Infectious Diseases. 10(2). 171–177. 51 indexed citations
19.
Erbay, Ayşe, et al.. (2000). Tularemia in the Ankara region.. 14(4). 453–458. 3 indexed citations
20.
Erbay, Ayşe, et al.. (2000). Ankara yöresinde tularemi. 14(4). 453–458. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026